| human | Q5 |
| P1960 | Google Scholar author ID | jFBRxCcAAAAJ |
| P6634 | LinkedIn personal profile ID | samantha-hinsley-0ba1945a |
| P496 | ORCID iD | 0000-0001-6903-4688 |
| P2038 | ResearchGate profile ID | Samantha_Hinsley |
| P2002 | X username | sam_hins |
| P1416 | affiliation | Leeds Institute of Clinical Trials Research | Q26226456 |
| P69 | educated at | University of Lancaster | Q262854 |
| P108 | employer | University of Glasgow | Q192775 |
| University of Leeds | Q503424 | ||
| University of Leeds Clinical Trials Research Unit | Q101046597 | ||
| P734 | family name | Hinsley | Q37458635 |
| Hinsley | Q37458635 | ||
| Hinsley | Q37458635 | ||
| P735 | given name | Samantha | Q6774 |
| Samantha | Q6774 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q57560974 | Abstract P3-11-04: Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials: |
| Q38230839 | Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial |
| Q52653865 | Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study. |
| Q96590073 | Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE) |
| Q37055591 | Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials |
| Q42353451 | Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peri |
| Q112717190 | Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer |
| Q37175657 | Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity |
| Q47110989 | Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer - An AZURE (BIG 01/04) sub-study |
| Q37497743 | The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage |
Search more.